Citrus aurantifulia extract as a capping agent to biosynthesis of gold nanoparticles: Characterization and evaluation of cytotoxicity, antioxidant, antidiabetic, anticholinergics, and anti‐bladder cancer activity

Therapeutic strategy of biological macromolecules based natural bioactive compounds of diabetes mellitus and future perspectives: A systematic review

High blood glucose levels are a hallmark of the metabolic syndrome known as diabetes mellitus. More than 600 million people will have diabetes by 2045 as the global prevalence of the disease continues to rise. Contemporary antidiabetic drugs reduce hyperglycemia and its consequences. However, these drugs come with undesirable side effects, so it's encouraging that research into plant extracts and bioactive substances with antidiabetic characteristics is on the rise. Natural remedies are preferable to conventional anti-diabetic drugs since they are safer for the body, more affordable and have fewer potential adverse effects. Biological macromolecules such as liposomes, niosomes, polymeric nanoparticles, solid lipid nanoparticles, nanoemulsions and metallic nanoparticles are explored in this review. Current drug restrictions have been addressed, and the effectiveness of plant-based antidiabetic therapies has enhanced the merits of these methods. Plant extracts' loading capacity and the carriers' stability are the primary obstacles in developing plant-based nanocarriers. Hydrophilic, hydrophobic, and amphiphilic drugs are covered, and a brief overview of the amphipathic features of liposomes, phospholipids, and lipid nanocarriers is provided. Metallic nanoparticles' benefits and attendant risks are highlighted to emphasize their efficiency in treating hyperglycemia. Researchers interested in the potential of nanoparticles loaded with plant extracts as antidiabetic therapeutics may find the current helpful review.

A Review on the Delivery of Plant-Based Antidiabetic Agents Using Nanocarriers: Current Status and Their Role in Combatting Hyperglycaemia

Diabetes mellitus is a prevalent metabolic syndrome that is associated with high blood glucose levels. The number of diabetic patients is increasing every year and the total number of cases is expected to reach more than 600 million worldwide by 2045. Modern antidiabetic drugs alleviate hyperglycaemia and complications that are caused by high blood glucose levels. However, due to the side effects of these drugs, plant extracts and bioactive compounds with antidiabetic properties have been gaining attention as alternative treatments for diabetes. Natural products are biocompatible, cheaper and expected to cause fewer side effects than the current antidiabetic drugs. In this review, various nanocarrier systems are discussed, such as liposomes, niosomes, polymeric nanoparticles, nanoemulsions, solid lipid nanoparticles and metallic nanoparticles. These systems have been applied to overcome the limitations of the current drugs and simultaneously improve the efficacy of plant-based antidiabetic drugs. The main challenges in the formulation of plant-based nanocarriers are the loading capacity of the plant extracts and the stability of the carriers. A brief review of lipid nanocarriers and the amphipathic properties of phospholipids and liposomes that encapsulate hydrophilic, hydrophobic and amphiphilic drugs is also described. A special emphasis is placed on metallic nanoparticles, with their advantages and associated complications being reported to highlight their effectiveness for treating hyperglycaemia. The present review could be an interesting paper for researchers who are working in the field of using plant extract-loaded nanoparticles as antidiabetic therapies.

Environmentally Safe Biosynthesis of Gold Nanoparticles Using Plant Water Extracts

Due to their simplicity of synthesis, stability, and functionalization, low toxicity, and ease of detection, gold nanoparticles (AuNPs) are a natural choice for biomedical applications. AuNPs’ unique optoelectronic features have subsequently been investigated and used in high-tech applications such as organic photovoltaics, sensory probes, therapeutic agents, the administration of drugs in biological and medical applications, electronic devices, catalysis, etc. Researchers have demonstrated the biosynthesis of AuNPs using plants. The present study evaluates 109 plant species used in the traditional medicine of Middle East countries as new sources of AuNPs in a wide variety of laboratory environments. In this study, dried samples of bark, bulb, flower, fruit, gum, leaf, petiole, rhizome, root, seed, stamen, and above-ground parts were evaluated in water extracts. About 117 plant parts were screened from 109 species in 54 plant families, with 102 extracts demonstrating a bioreduction of Au³⁺ to Au⁰, revealing 37 new plant species in this regard. The color change of biosynthesized AuNPs to gray, violet, or red was confirmed by UV-Visible spectroscopy, TEM, FSEM, DLS, and EDAX of six plants. In this study, AuNPs of various sizes were measured from 27 to 107 nm. This study also includes an evaluation of the potency of traditional East Asian medicinal plants used in this biosynthesis of AuNPs. An environmentally safe procedure such as this could act as a foundation for cosmetic industries whose quality assessment systems give a high priority to non-chemically synthesized products. It is crucial that future optimizations are adequately documented to scale up the described process.